Literature DB >> 26071409

Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient.

M Martínez-Montiel1, Pilar Piedracoba-Cadahia2, Carlos Gómez-Gómez2, J Gonzalo2.   

Abstract

Entities:  

Keywords:  Crohn’s disease; anti-TNFα; orthotopic liver transplant; ustekinumab

Mesh：

Substances：

Year:  2015        PMID： 26071409     DOI： 10.1093/ecco-jcc/jjv109

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  2 in total

1.  TNF-alpha inhibitors and ustekinumab for the treatment of psoriasis: therapeutic utility in the era of IL-17 and IL-23 inhibitors.

Authors:  Julie J Hong; Edward K Hadeler; Megan L Mosca; Nicholas D Brownstone; Tina Bhutani; Wilson J Liao
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2022-01-12

2.  Infliximab-Induced Acute Liver Failure in a Patient With Crohn's Disease Requiring Orthotopic Liver Transplantation.

Authors:  Muhammed Mustafa Alikhan; Emad Mansoor; Sagarika Satyavada; Katarina Greer; Wei Xin; Stanley Cohen; Gregory Cooper; Jeffry Katz
Journal:  ACG Case Rep J       Date:  2021-05-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.